Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation

RACE 7 ACWAS Investigators

Research output: Contribution to journalArticleAcademicpeer-review

127 Citations (Scopus)

Abstract

BACKGROUND: Patients with recent-onset atrial fibrillation commonly undergo immediate restoration of sinus rhythm by pharmacologic or electrical cardioversion. However, whether immediate restoration of sinus rhythm is necessary is not known, since atrial fibrillation often terminates spontaneously.

METHODS: In a multicenter, randomized, open-label, noninferiority trial, we randomly assigned patients with hemodynamically stable, recent-onset (<36 hours), symptomatic atrial fibrillation in the emergency department to be treated with a wait-and-see approach (delayed-cardioversion group) or early cardioversion. The wait-and-see approach involved initial treatment with rate-control medication only and delayed cardioversion if the atrial fibrillation did not resolve within 48 hours. The primary end point was the presence of sinus rhythm at 4 weeks. Noninferiority would be shown if the lower limit of the 95% confidence interval for the between-group difference in the primary end point in percentage points was more than -10.

RESULTS: The presence of sinus rhythm at 4 weeks occurred in 193 of 212 patients (91%) in the delayed-cardioversion group and in 202 of 215 (94%) in the early-cardioversion group (between-group difference, -2.9 percentage points; 95% confidence interval [CI], -8.2 to 2.2; P = 0.005 for noninferiority). In the delayed-cardioversion group, conversion to sinus rhythm within 48 hours occurred spontaneously in 150 of 218 patients (69%) and after delayed cardioversion in 61 patients (28%). In the early-cardioversion group, conversion to sinus rhythm occurred spontaneously before the initiation of cardioversion in 36 of 219 patients (16%) and after cardioversion in 171 patients (78%). Among the patients who completed remote monitoring during 4 weeks of follow-up, a recurrence of atrial fibrillation occurred in 49 of 164 patients (30%) in the delayed-cardioversion group and in 50 of 171 (29%) in the early-cardioversion group. Within 4 weeks after randomization, cardiovascular complications occurred in 10 patients and 8 patients, respectively.

CONCLUSIONS: In patients presenting to the emergency department with recent-onset, symptomatic atrial fibrillation, a wait-and-see approach was noninferior to early cardioversion in achieving a return to sinus rhythm at 4 weeks. (Funded by the Netherlands Organization for Health Research and Development and others; RACE 7 ACWAS ClinicalTrials.gov number, NCT02248753.).

Original languageEnglish
Pages (from-to)1499-1508
Number of pages10
JournalNew England journal of medicine
Volume380
Issue number16
DOIs
Publication statusPublished - 18 Apr 2019

Keywords

  • Adrenergic beta-Antagonists/therapeutic use
  • Aged
  • Anti-Arrhythmia Agents/adverse effects
  • Atrial Fibrillation/drug therapy
  • Calcium Channel Blockers/therapeutic use
  • Digoxin/therapeutic use
  • Electric Countershock/adverse effects
  • Emergency Service, Hospital
  • Female
  • Heart Rate
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Quality of Life
  • Recurrence
  • Time-to-Treatment
  • Treatment Outcome

Cite this